KEMYTH BIOTECH
KeMyth Biotech, established in July 2015, focuses on transforming research achievements into industry innovation. The company has expanded its focus from infectious diseases to broader health challenges, developing core projects such as antibiotic testing and screening platforms, rapid diagnostic reagents, new drug development, and beauty and health products. With a professional team and industry partnerships, KeMyth Biotech aims to enhance medical quality, improve human health and quality of life, and lead the development of the biotech industry through continuous innovation and global market expansion.
Industries
Nr. of Employees
small (1-50)
KEMYTH BIOTECH
Patents
Treatment of diabetes, toll-like receptor 4 modulators and methods for using the same
US-10287328-B2
View Details
Treatment of diabetes, toll-like receptor 4 modulators and methods for using the same
US-10287328-B2
View DetailsProducts
Antibiotic testing and screening platform
Platform to evaluate and screen antibacterial compounds for antimicrobial activity and candidate selection.
Klebsiella pneumoniae K1/K2 serotyping antigen diagnostic reagent
Antigen-based diagnostic reagent for serotyping Klebsiella pneumoniae capsular types K1 and K2.
Cosmetics and health product line (natural-extract formulations)
Series of natural-extract cosmetic and health products developed using advanced extraction techniques and formulation methods.
Antibiotic testing and screening platform
Platform to evaluate and screen antibacterial compounds for antimicrobial activity and candidate selection.
Klebsiella pneumoniae K1/K2 serotyping antigen diagnostic reagent
Antigen-based diagnostic reagent for serotyping Klebsiella pneumoniae capsular types K1 and K2.
Cosmetics and health product line (natural-extract formulations)
Series of natural-extract cosmetic and health products developed using advanced extraction techniques and formulation methods.
Services
Contract preclinical PK and biodistribution studies to determine ADME and tissue distribution of compounds.
Contract preclinical PK and biodistribution studies to determine ADME and tissue distribution of compounds.
Expertise Areas
- Antibiotic screening and susceptibility testing
- Diagnostic reagent development and serotyping
- Pharmacokinetics and biodistribution studies
- Natural product extraction and formulation
Key Technologies
- Antibiotic screening platforms
- Antigen-based diagnostic assays
- Bacterial capsular serotyping assays
- Pharmacokinetic and biodistribution assays
News & Updates
Approval for medical equipment.
Obtained Taiwanese patent for the antibiotic testing and screening platform (Invention No. I778025).
Obtained US patent for the antibiotic testing and screening platform (Patent No. KMB0002US).
Received the 13th Taiwan National Innovation Award for rapid identification technology of Klebsiella pneumoniae capsule serotype.
Received the 13th Taiwan National Innovation Award for rapid identification technology of Klebsiella pneumoniae capsule serotype.
Approval for medical equipment.
Obtained Taiwanese patent for the antibiotic testing and screening platform (Invention No. I778025).
Obtained US patent for the antibiotic testing and screening platform (Patent No. KMB0002US).
Received the 13th Taiwan National Innovation Award for rapid identification technology of Klebsiella pneumoniae capsule serotype.
Received the 13th Taiwan National Innovation Award for rapid identification technology of Klebsiella pneumoniae capsule serotype.